[Dr. Milos-Misa Cirić, pneumophthisiologist (1893-1979)].

Ž. Mikić,D. Lazić

Medicinski pregled

Abstract:

What problem does this paper attempt to address?

Mobile Health Interventions: A Frontier for Mitigating the Global Burden of Cardiovascular Disease

Maryyam Liaqat,Maham Mushtaq,Ahmed Jamil,Muhammad Muaz Mushtaq,Husnain Ali,Rahma Anwar,Ahmad Raza,Asma Aslam,Tamseer Tariq,Muzaffer Hussain,Danyal Bakht,Syed Faqeer Hussain Bokhari

DOI: https://doi.org/10.7759/cureus.62157

2024-06-11

Cureus

Abstract:Mobile health (mHealth) interventions have emerged as a promising approach for cardiovascular disease (CVD) prevention and management. The proliferation of smartphones and wearable devices enables convenient access to health monitoring tools, educational resources, and communication with healthcare providers. mHealth interventions encompass mobile apps, wearables, and telehealth services that empower users to monitor vital signs, adhere to medication, and adopt healthier lifestyles. Their effectiveness hinges on user engagement, leveraging behavioral science principles and gamification strategies. While mHealth offers advantages such as personalized support and increased reach, it faces challenges pertaining to data privacy, security concerns, and resistance from healthcare providers. Robust encryption and adherence to regulations like the Health Insurance Portability and Accountability Act (HIPAA) are crucial for safeguarding sensitive health data. Integrating mHealth into clinical workflows can enhance healthcare delivery, but organizational adjustments are necessary. The future of mHealth is closely intertwined with artificial intelligence (AI), enabling remote monitoring, predictive algorithms, and data-driven insights. Tech giants are incorporating advanced health-tracking capabilities into their devices, paving the way for personalized wellness approaches. However, mHealth grapples with ethical dilemmas surrounding data ownership, privacy breaches, and inadvertent data capture. Despite its potential, mHealth necessitates a concerted effort to overcome obstacles and ensure ethical, secure, and practical implementation. Addressing technical challenges, fostering standardization, and promoting equitable access are pivotal for unlocking the transformative impact of mHealth on cardiovascular health and reducing the global burden of CVD.
Mobile Health Devices as Tools for Worldwide Cardiovascular Risk Reduction and Disease Management

John D Piette,Justin List,Gurpreet K Rana,Whitney Townsend,Dana Striplin,Michele Heisler

DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.008723

IF: 37.8

2015-11-24

Circulation

Abstract:We examined evidence on whether mobile health (mHealth) tools, including interactive voice response calls, short message service, or text messaging, and smartphones, can improve lifestyle behaviors and management related to cardiovascular diseases throughout the world. We conducted a state-of-the-art review and literature synthesis of peer-reviewed and gray literature published since 2004. The review prioritized randomized trials and studies focused on cardiovascular diseases and risk factors, but included other reports when they represented the best available evidence. The search emphasized reports on the potential benefits of mHealth interventions implemented in low- and middle-income countries. Interactive voice response and short message service interventions can improve cardiovascular preventive care in developed countries by addressing risk factors including weight, smoking, and physical activity. Interactive voice response and short message service-based interventions for cardiovascular disease management also have shown benefits with respect to hypertension management, hospital readmissions, and diabetic glycemic control. Multimodal interventions including Web-based communication with clinicians and mHealth-enabled clinical monitoring with feedback also have shown benefits. The evidence regarding the potential benefits of interventions using smartphones and social media is still developing. Studies of mHealth interventions have been conducted in >30 low- and middle-income countries, and evidence to date suggests that programs are feasible and may improve medication adherence and disease outcomes. Emerging evidence suggests that mHealth interventions may improve cardiovascular-related lifestyle behaviors and disease management. Next-generation mHealth programs developed worldwide should be based on evidence-based behavioral theories and incorporate advances in artificial intelligence for adapting systems automatically to patients' unique and changing needs.
Evaluation of mHealth Applications Related to Cardiovascular Diseases: a Systematic Review

Vladimir Villarreal,Aranzazu Berbey-Alvarez

DOI: https://doi.org/10.5455/aim.2020.28.130-137

Abstract:Introduction: Currently, with the widespread penetration of mobile devices with Internet access, including smartphones, they can allow specific and/or complementary activities in the health field as well as in other commercial sectors. Aim: This systematic review examined the impact of mHealth-based for cardiovascular research. The specific aims of the systematic review are to (1) classification of the studies according to the type of research (scientific articles and master's and doctoral theses) and (2) relationship of studies with topics associated with cardiovascular diseases. Results: This review corresponds to information in scientific journals of high impact. This review intends to respond to the following question: How these research works have evaluated the performance of health mobile applications, with a special interest in cardiac issues? This review of these searches corresponds to an analysis by 14 categories, being these: 1) Scientific paper; 2) Doctoral Thesis; 3) Master thesis; 4) Telemedicine; 5) m-sssshealth, e-health; 6) cardiovascular, coronary diseases, heart failures, cardiopulmonary, cardiac rehabilitation; 7) rural health; 8) prevention and control, protection; 9) wearables; 10) mobile, web applications, app, smartphone, software, platform; 11) mhealth education, training, promotion, formative process; 12) self-management; 13) Multiple Vital Sign Monitoring, medical device, heart rate measurement, health care information systems; 14) health regulatory. It provides evidence of how some apps have been evaluated, and in some cases, the effectiveness of the estimated accuracy is not in line with the real situation. Conclusion: The analysis of these studies allows us to locate the sources of the development of mobile health projects. It also guides us to discover some needs that require new technology implementations.
Controlling Toxicity of Peptide–Drug Conjugates by Different Chemical Linker Structures

David Böhme,A. Beck‐Sickinger

DOI: https://doi.org/10.1002/cmdc.201402514

IF: 3.54

2015-05-01

ChemMedChem

Abstract:The side effects of chemotherapy can be overcome by linking toxic agents to tumor‐targeting peptides with cleavable linkers. Herein, this concept is demonstrated by addressing the human Y1 receptor (hY1R), overexpressed in breast tumors, with analogues of the hY1R‐preferring [F7,P34]NPY. First, carboxytetramethylrhodamine was connected to [F7,P34]NPY by an amide, ester, disulfide, or enzymatic linkage. Live imaging revealed hY1R‐mediated delivery and allowed visualization of time‐dependent intracellular release. Next, the fluorophore was replaced by the toxic agent methotrexate (MTX). In addition to linkage through the amide, ester, disulfide bond, or enzymatic cleavage site, a novel disulfide/ester linker was designed and coupled to [F7,P34]NPY by solid‐phase peptide synthesis. Internalization studies showed hY1R subtype selective uptake, and cell viability experiments demonstrated hY1R‐mediated toxicity that was clearly dependent on the linkage type. Fast release profiles for fluorophore‐[F7,P34]NPY analogues correlated with high toxicities of MTX conjugates carrying the same linker types and emphasize the relevance of new structures connecting the toxophore and the carrier.
Mobile Health (mHealth) Technology for the Management of Hypertension and Hyperlipidemia: Slow Start but Loads of Potential

Hasan Rehman,Ayeesha K. Kamal,Pamela B. Morris,Saleem Sayani,Anwar T. Merchant,Salim S. Virani

DOI: https://doi.org/10.1007/s11883-017-0649-y

IF: 5.967

2017-02-13

Current Atherosclerosis Reports

Abstract:Purpose of ReviewHypertension and hyperlipidemia represent two major risk factors for atherosclerotic cardiovascular disease. Mobile health or mHealth is defined as the use of mobile phone and wireless technologies to support the achievement of health objectives. Management of hypertension, and to some extent hyperlipidemia, has often employed mHealth interventions given lower cost and greater patient engagement compared to traditional methods. These interventions include the use of text messaging, wireless devices, and mobile phone applications. This review considers recent studies evaluating the effectiveness of mHealth interventions in the management of hypertension and hyperlipidemia.Recent FindingsNumerous studies have evaluated the role of mHealth interventions in the management of hypertension, while very few have evaluated their role in hyperlipidemia. Text messaging has been used most frequently. However, the trend is shifting towards the use of mobile phone applications and wireless devices. Interventions in developing countries have been modified for greater applicability to local settings. mHealth interventions were found to be frequently effective. However, studies comparing the relative efficacy of various mHealth strategies are scarce. Long-term cardiovascular outcomes data and analyses relating to cost effectiveness are also lacking.SummarymHealth interventions may be effective in improving hypertension management. More studies are needed to evaluate the role of mHealth strategies in hyperlipidemia management, particularly in identifying high-risk individuals and improving medication adherence. Studies assessing the long-term impact of these interventions, comparing different interventions and analyzing their relative cost effectiveness, are also needed. Following recently published guidelines on reporting results of mHealth interventions will provide a more meaningful context for interpreting these promising early studies.

peripheral vascular disease
Interpretability Improvements to Find the Balance Interpretability-Accuracy in Fuzzy Modeling: An Overview

J. Casillas,O. Cordón,F. Herrera,L. Magdalena

DOI: https://doi.org/10.1007/978-3-540-37057-4_1

Abstract:
Impact of mHealth Interventions on Supporting Dietary Adherence in Cardiovascular Disease: A Systematic Review

Sarah J M Thom,Bridve Sivakumar,Temitope Ayodele,Maria C Tan,Jacqueline Marie Brown,JoAnne Arcand

DOI: https://doi.org/10.1016/j.jneb.2023.03.004

Abstract:Introduction: A systematic review was conducted to determine if mobile health (mHealth) interventions, and which intervention characteristics, effectively support dietary adherence and reduce risk factors in patients with cardiovascular disease (CVD). Method: Using 7 databases, studies involving adult participants with specific CVD diagnoses, mHealth intervention testing, and dietary adherence assessment were identified. Systematic reviews, qualitative studies, or studies testing interventions involving open dialogue between participants and health care providers or researchers were excluded. Two independent reviewers conducted screening and assessed the risk of bias. Results: Thirteen studies involved participants with prehypertension (n = 1), hypertension (n = 9), coronary artery disease (n = 2), and heart failure (n = 1). mHealth interventions in 8 studies improved dietary adherence, 4 showed mixed results, and 1 showed no improvements. Eight studies found interactive text and/or application-based mHealth intervention features effectively improved dietary adherence. One study had a low risk of bias, 2 had some concerns/moderate risk, and 10 had a high/critical or serious risk. Discussion: In most included studies, mHealth interventions positively impacted dietary adherence for patients with CVD. Implications for research and practice: Clinicians may recommend mHealth interventions to support nutrition education and self-management for their patients with CVD.
mHealth Apps for Self-Management of Cardiovascular Diseases: A Scoping Review

Nancy Aracely Cruz-Ramos,Giner Alor-Hernández,Luis Omar Colombo-Mendoza,José Luis Sánchez-Cervantes,Lisbeth Rodríguez-Mazahua,Luis Rolando Guarneros-Nolasco

DOI: https://doi.org/10.3390/healthcare10020322

2022-02-08

Abstract:The use of mHealth apps for the self-management of cardiovascular diseases (CVDs) is an increasing trend in patient-centered care. In this research, we conduct a scoping review of mHealth apps for CVD self-management within the period 2014 to 2021. Our review revolves around six main aspects of the current status of mHealth apps for CVD self-management: main CVDs managed, main app functionalities, disease stages managed, common approaches used for data extraction, analysis, management, common wearables used for CVD detection, monitoring and/or identification, and major challenges to overcome and future work remarks. Our review is based on Arksey and O'Malley's methodological framework for conducting studies. Similarly, we adopted the PRISMA model for reporting systematic reviews and meta-analyses. Of the 442 works initially retrieved, the review comprised 38 primary studies. According to our results, the most common CVDs include arrhythmia (34%), heart failure (32%), and coronary heart disease (18%). Additionally, we found that the majority mHealth apps for CVD self-management can provide medical recommendations, medical appointments, reminders, and notifications for CVD monitoring. Main challenges in the use of mHealth apps for CVD self-management include overcoming patient reluctance to use the technology and achieving the interoperability of mHealth applications with other systems.
Engineering a mobile health tool for resource-poor settings to assess and manage cardiovascular disease risk: SMARThealth study

Arvind Raghu,Devarsetty Praveen,David Peiris,Lionel Tarassenko,Gari Clifford

DOI: https://doi.org/10.1186/s12911-015-0148-4

IF: 3.298

2015-04-29

BMC Medical Informatics and Decision Making

Abstract:BackgroundThe incidence of chronic diseases in low- and middle-income countries is rapidly increasing both in urban and rural regions. A major challenge for health systems globally is to develop innovative solutions for the prevention and control of these diseases. This paper discusses the development and pilot testing of SMARTHealth, a mobile-based, point-of-care Clinical Decision Support (CDS) tool to assess and manage cardiovascular disease (CVD) risk in resource-constrained settings. Through pilot testing, the preliminary acceptability, utility, and efficiency of the CDS tool was obtained.MethodsThe CDS tool was part of an mHealth system comprising a mobile application that consisted of an evidence-based risk prediction and management algorithm, and a server-side electronic medical record system. Through an agile development process and user-centred design approach, key features of the mobile application that fitted the requirements of the end users and environment were obtained. A comprehensive analytics framework facilitated a data-driven approach to investigate four areas, namely, system efficiency, end-user variability, manual data entry errors, and usefulness of point-of-care management recommendations to the healthcare worker. A four-point Likert scale was used at the end of every risk assessment to gauge ease-of-use of the system.ResultsThe system was field-tested with eleven village healthcare workers and three Primary Health Centre doctors, who screened a total of 292 adults aged 40 years and above. 34% of participants screened by health workers were identified by the CDS tool to be high CVD risk and referred to a doctor. In-depth analysis of user interactions found the CDS tool feasible for use and easily integrable into the workflow of healthcare workers. Following completion of the pilot, further technical enhancements were implemented to improve uptake of the mHealth platform. It will then be evaluated for effectiveness and cost-effectiveness in a cluster randomized controlled trial involving 54 southern Indian villages and over 16000 individuals at high CVD risk.ConclusionsAn evidence-based CVD risk prediction and management tool was used to develop an mHealth platform in rural India for CVD screening and management with proper engagement of health care providers and local communities. With over a third of screened participants being high risk, there is a need to demonstrate the clinical impact of the mHealth platform so that it could contribute to improved CVD detection in high risk low resource settings.

medical informatics
Double-blind comparison between nalbuphine and pentazocine in the control of postoperative pain after orthopedic surgery.

R. Donadoni,G. Rolly,J. Devulder,R. Verdonck

Abstract:A double blind randomized study was done to compare Nalbuphine 20 mg I.M. to pentazocine 30 mg I.M. for postoperative pain relief after orthopedic surgery. This dose of pentazocine was choosen according to reports in the literature and to our standard practice. Sixty patients entered the study and were observed regularly till up 6 h post injection. The test drug was given when a pain score of 6 was shown on a VAS from 0 to 10. Onset, duration and quality of pain relief were significantly superior for nalbuphine with 50% of the patients still having no or only moderate pain at the end of the observation period. Cardiovascular and side effect were in both groups minor.
Technological Interventions to Implement Prevention and Health Promotion in Cardiovascular Patients

Ayisha Z. Bashir,Anji Yetman,Melissa Wehrmann

DOI: https://doi.org/10.3390/healthcare12202055

2024-10-17

Health Care

Abstract:Background/Objectives: The aim of the narrative review is to identify information on the impact of technological interventions (such as telehealth and mobile health) on the health promotion of cardiac patients from diverse populations. Methods: The online databases of PubMed and the Cochrane Library were searched for articles in the English language regarding technological interventions for health promotion in cardiac patients. In addition, a methodological quality control process was conducted. Exclusion was based on first reading the abstract, and then the full manuscript was scanned to confirm that the content was not related to cardiac patients and technological interventions. Results: In all, 11 studies were included in this review after quality control analysis. The sample size reported in these studies ranged from 12 to 1424 subjects. In eight studies mobile phones, smartphones, and apps were used as mHealth interventions with tracking and texting components; two studies used videoconferencing as a digital intervention program, while three studies focused on using physical activity trackers. Conclusions: This review highlights the positive aspects of patient satisfaction with the technological interventions including, but not limited to, accessibility to health care providers, sense of security, and well-being. The digital divide becomes apparent in the articles reviewed, as individuals with limited eHealth literacy and lack of technological knowledge are not motivated or able participate in these interventions. Finding methods to overcome these barriers is important and can be solved to some extent by providing the technology and technical support.

health care sciences & services,health policy & services
2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals

Niraj Varma,Iwona Cygankiewicz,Mintu P. Turakhia,Hein Heidbuchel,Yufeng Hu,Lin Yee Chen,Jean-Philippe Couderc,Edmond M. Cronin,Jerry D. Estep,Lars Grieten,Deirdre A. Lane,Reena Mehra,Alex Page,Rod Passman,Jonathan P. Piccini,Ewa Piotrowicz,Ryszard Piotrowicz,Pyotr G. Platonov,Antonio Luiz Ribeiro,Robert E. Rich,Andrea M. Russo,David Slotwiner,Jonathan S. Steinberg,Emma Svennberg

DOI: https://doi.org/10.1016/j.cvdhj.2020.11.004

2021-02-01

Cardiovascular Digital Health Journal

Abstract:This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society describes the current status of mobile health ("mHealth") technologies in arrhythmia management. The range of digital medical tools and heart rhythm disorders that they may be applied to and clinical decisions that may be enabled are discussed. The facilitation of comorbidity and lifestyle management (increasingly recognized to play a role in heart rhythm disorders) and patient self-management are novel aspects of mHealth. The promises of predictive analytics but also operational challenges in embedding mHealth into routine clinical care are explored.
Harnessing Mobile Health Technology for Secondary Cardiovascular Disease Prevention in Older Adults: A Scientific Statement From the American Heart Association

Erica N. Schorr,Adam D. Gepner,Mary A. Dolansky,Daniel E. Forman,Linda G. Park,Kristina S. Petersen,Carolyn H. Still,Tracy Y. Wang,Nanette K. Wenger,On behalf of the American Heart Association Cardiovascular Disease in Older Populations Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing; Council on Arteriosclerosis Thrombosis and Vascular Biology; and Council on Lifestyle and Cardiometabolic Health,

DOI: https://doi.org/10.1161/hcq.0000000000000103

2021-05-01

Abstract:Secondary prevention of cardiovascular disease (CVD), the leading cause of morbidity and mortality, is critical to improving health outcomes and quality of life in our aging population. As mobile health (mHealth) technology gains universal leverage and popularity, it is becoming more user-friendly for older adults and an adjunct to manage CVD risk and improve overall cardiovascular health. With the rapid advances in mHealth technology and increasing technological engagement of older adults, a comprehensive understanding of the current literature and knowledge of gaps and barriers surrounding the impact of mHealth on secondary CVD prevention is essential. After a systematic review of the literature, 26 studies that used mHealth for secondary CVD prevention focusing on lifestyle behavior change and medication adherence in cohorts with a mean age of ≥60 years were identified. Improvements in health behaviors and medication adherence were observed, particularly when there was a short message service (ie, texting) component involved. Although mobile technologies are becoming more mainstream and are starting to blend more seamlessly with standard health care, there are still distinct barriers that limit implementation particularly in older adults, including affordability, usability, privacy, and security issues. Furthermore, studies on the type of mHealth that is the most effective for older adults with longer study duration are essential as the field continues to grow. As our population ages, identifying and implementing effective, widely accepted, cost-effective, and time-efficient mHealth interventions to improve CVD health in a vulnerable demographic group should be a top health priority.

cardiac & cardiovascular systems
Mobile Health Technology: a Novel Tool in Chronic Disease Management

Kaman Fan,Yi Zhao

DOI: https://doi.org/10.1016/j.imed.2021.06.003

2022-01-01

Intelligent Medicine

Abstract:The successful control of chronic diseases mainly depends on how well patients manage their disease conditions with the aid of healthcare providers. Mobile health technology -also known as mHealth -supports healthcare practice by means of mobile devices such as smartphone applications, web-based technologies, telecommunications services, social media, and wearable technology, and is becoming increasingly popular. Many studies have evaluated the utility of mHealth as a tool to improve chronic disease management through monitoring and feedback, educational and lifestyle interventions, clinical decision support, medication adherence, risk screening, and rehabilitation support. The aim of this article is to summarize systematic reviews addressing the effect of mHealth on the outcome of patients with chronic diseases. We describe the current applications of various mHealth approaches, evaluate their effectiveness as well as limitations, and discuss potential challenges in their future development. The evidence to date indicates that none of the existing mHealth technologies are inferior to traditional care. Telehealth and web-based technologies are the most frequently reported interventions, with promising results ranging from alleviation of disease-related symptoms, improvement in medication adherence, and decreased rates of rehospitalization and mortality. The new generation of mHealth devices based on various technologies are likely to provide more efficient and personalized healthcare programs for patients.
Use of mobile health applications for health-promoting behavior among individuals with chronic medical conditions

Asos Mahmood,Satish Kedia,David K Wyant,SangNam Ahn,Soumitra S Bhuyan

DOI: https://doi.org/10.1177/2055207619882181

2019-01-01

Digital Health

Abstract:Background Chronic medical conditions (CCs) are leading causes of morbidity and mortality in the United States. Strategies to control CCs include targeting unhealthy behaviors, often through the use of patient empowerment tools, such as mobile health (mHealth) technology. However, no conclusive evidence exists that mHealth applications (apps) are effective among individuals with CCs for chronic disease self-management. Methods We used data from the Health Information National Trends Survey (HINTS 5, Cycle 1, 2017). A sample of 1864 non-institutionalized US adults (≥18 years) who had a smartphone and/or a tablet computer and at least one CC was analyzed. Using multivariable logistic regressions, we assessed predisposing, enabling, and need predictors of three health-promoting behaviors (HPBs): tracking progress on a health-related goal, making a health-related decision, and health-related discussions with a care provider among smart device and mHealth apps owners. Results Compared to those without mHealth apps, individuals with mHealth apps had significantly higher odds of using their smart devices to track progress on a health-related goal (adjusted odds ratio (aOR) 8.74, 95% confidence interval (CI): 5.66–13.50, P < .001), to make a health-related decision (aOR 1.77, 95% CI: 1.16–2.71, P < .01) and in health-related discussions with care providers (aOR 2.0, 95% CI: 1.26–3.19, P < .01). Other significant factors of at least one type of HPB among smart device and mHealth apps users were age, gender, education, occupational status, having a regular provider, and self-rated general health. Conclusion mHealth apps are associated with increased rates of HPB among individuals with CCs. However, certain groups, like older adults, are most affected by a digital divide where they have lower access to mHealth apps and thus are not able to take advantage of these tools. Rigorous randomized clinical trials among various segments of the population and different health conditions are needed to establish the effectiveness of these mHealth apps. Healthcare providers should encourage validated mHealth apps for patients with CCs.
Chapter Two - Privacy Challenges and Goals in mHealth Systems.

Farzana Rahman,Ivor D. Addo,Sheikh Iqbal Ahamed,Ji-Jiang Yang,Qing Wang

DOI: https://doi.org/10.1016/bs.adcom.2016.05.004

IF: 3.067

2016-01-01

Advances in Computers

Abstract:The global phenomena of mobile technology have encouraged collaborations between national governments and diverse international stakeholders in applying mobile-based health (mHealth) solutions as a powerful opportunity for improving health and development in rural and remote areas. A significant impact offered by modern mHealth technologies includes the potential to transform various aspects of healthcare, improving accessibility, quality, and affordability. Over the years, mHealth has become important in the field of healthcare information technology as patients begin to use mobile-based medical sensors to record their daily activities and vital signs. The rapid expansion of mobile information and communications technologies within health service delivery and public health systems has created a range of new opportunities to deliver new forms of interactive health services to patients, clinicians, and caregivers alike. The scope and scale of mHealth interventions range from simple direct-to-individual consumer and interactive patient-provider communications to more complex computer-based systems facilitating coordinated patient care and management.
Mobile health apps for cardiovascular risk assessment: a systematic review

Fabian A Chavez-Ecos,Rodrigo Chavez-Ecos,Carlos Vergara Sanchez,Miguel A Chavez-Gutarra,Anandita Agarwala,Kiara Camacho-Caballero

DOI: https://doi.org/10.3389/fcvm.2024.1420274

2024-09-23

Abstract:Introduction: mHealth apps (MHA) are emerging as promising tools for cardiovascular risk assessment, but few meet the standards required for clinical use. We aim to evaluate the quality and functionality of mHealth apps for cardiovascular risk assessment by healthcare professionals. Methods: We conducted a systematic review of MHA for cardiovascular risk assessment in the Apple Store, Play Store, and Microsoft Store until August 2023. Our eligibility criteria were based on the 2021 European Society Cardiology Guidelines on Cardiovascular Disease Prevention in Clinical Practice, the Framingham Risk Score, and the Atherosclerotic Cardiovascular Disease score. Our protocol was drafted using the Preferred Reporting items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. To assess quality, we used the validated Mobile Apps Rating Scale (MARS) score, which includes 19 items across four objective scales (engagement, functionality, aesthetics, and information quality) and one additional subjective scale. For functionality evaluation, we used the IMS Institute for Healthcare Informatics functionality scale. We performed data synthesis by generating descriptive statistics. Results: A total of 18 MHA were included in the review. The most common scores used were the Framingham score, ASCVD score, and Score 2. Only six apps achieved an overall score of 4 or greater in the MARS evaluation. The MHA with the highest MARS score was ESC CVD Risk Calculation (5 points), followed by ASCVD Risk Estimator Plus (4.9 points). In the IMS scale, four MHA had a high functionality score: ASCVD Risk Estimator Plus (5 points), ESC CVD Risk Calculation (5 points), MDCalc Medical Calculator (4 points), and Calculate by QsMD (4 points). Discussion: A gap exists in the availability of high-quality MHA designed for healthcare professionals to facilitate shared decision-making in cardiovascular risk assessment. Systematic review registration: The International Prospective Register of Systematic Reviews, identifier CRD42023453807.
Privacy Challenges and Goals in mHealth Systems

Farzana Rahman,Ivor D. Addo,Sheikh Iqbal Ahamed,Ji-Jiang Yang,Qing Wang

DOI: https://doi.org/10.1016/bs.adcom.2016.05.004

2016-01-01

Abstract:The global phenomena of mobile technology have encouraged collaborations between national governments and diverse international stakeholders in applying mobile-based health (mHealth) solutions as a powerful opportunity for improving health and development in rural and remote areas. A significant impact offered by modern mHealth technologies includes the potential to transform various aspects of healthcare, improving accessibility, quality, and affordability. Over the years, mHealth has become important in the field of healthcare information technology as patients begin to use mobile-based medical sensors to record their daily activities and vital signs. The rapid expansion of mobile information and communications technologies within health service delivery and public health systems has created a range of new opportunities to deliver new forms of interactive health services to patients, clinicians, and caregivers alike. The scope and scale of mHealth interventions range from simple direct-to-individual consumer and interactive patient-provider communications to more complex computer-based systems facilitating coordinated patient care and management.
2021 ISHNE / HRS / EHRA / APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals

Niraj Varma,Iwona Cygankiewicz,Mintu Turakhia,Hein Heidbuchel,Yufeng Hu,Lin Yee Chen,Jean-Philippe Couderc,Edmond M Cronin,Jerry D Estep,Lars Grieten,Deirdre A Lane,Reena Mehra,Alex Page,Rod Passman,Jonathan Piccini,Ewa Piotrowicz,Ryszard Piotrowicz,Pyotr G Platonov,Antonio Luiz Ribeiro,Robert E Rich,Andrea M Russo,David Slotwiner,Jonathan S Steinberg,Emma Svennberg

DOI: https://doi.org/10.1093/ehjdh/ztab001

2021-01-29

Abstract:Abstract This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology / Heart Rhythm Society / European Heart Rhythm Association / Asia Pacific Heart Rhythm Society describes the current status of mobile health (“mHealth”) technologies in arrhythmia management. The range of digital medical tools and heart rhythm disorders that they may be applied to and clinical decisions that may be enabled are discussed. The facilitation of comorbidity and lifestyle management (increasingly recognized to play a role in heart rhythm disorders) and patient self-management are novel aspects of mHealth. The promises of predictive analytics but also operational challenges in embedding mHealth into routine clinical care are explored.
Diet-induced obesity delays cardiovascular recovery from stress in spontaneously hypertensive rats.

L. Šedová,J. Bérubé,D. Gaudet,M. Dumont,J. Tremblay,P. Hamet,Z. Pausova

DOI: https://doi.org/10.1038/OBY.2004.245

2004-12-01

Obesity Research

Abstract:

[Dr. Milos-Misa Cirić, pneumophthisiologist (1893-1979)].

Mobile Health Interventions: A Frontier for Mitigating the Global Burden of Cardiovascular Disease

Mobile Health Devices as Tools for Worldwide Cardiovascular Risk Reduction and Disease Management

Evaluation of mHealth Applications Related to Cardiovascular Diseases: a Systematic Review

Controlling Toxicity of Peptide–Drug Conjugates by Different Chemical Linker Structures

Mobile Health (mHealth) Technology for the Management of Hypertension and Hyperlipidemia: Slow Start but Loads of Potential

Interpretability Improvements to Find the Balance Interpretability-Accuracy in Fuzzy Modeling: An Overview

Impact of mHealth Interventions on Supporting Dietary Adherence in Cardiovascular Disease: A Systematic Review

mHealth Apps for Self-Management of Cardiovascular Diseases: A Scoping Review

Engineering a mobile health tool for resource-poor settings to assess and manage cardiovascular disease risk: SMARThealth study

Double-blind comparison between nalbuphine and pentazocine in the control of postoperative pain after orthopedic surgery.

Technological Interventions to Implement Prevention and Health Promotion in Cardiovascular Patients

2021 ISHNE/HRS/EHRA/APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals

Harnessing Mobile Health Technology for Secondary Cardiovascular Disease Prevention in Older Adults: A Scientific Statement From the American Heart Association

Mobile Health Technology: a Novel Tool in Chronic Disease Management

Use of mobile health applications for health-promoting behavior among individuals with chronic medical conditions

Chapter Two - Privacy Challenges and Goals in mHealth Systems.

Mobile health apps for cardiovascular risk assessment: a systematic review

Privacy Challenges and Goals in mHealth Systems

2021 ISHNE / HRS / EHRA / APHRS Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals

Diet-induced obesity delays cardiovascular recovery from stress in spontaneously hypertensive rats.